Feds seize $2 million worth of 'cosmetic' eye product
FDA says product contains unapproved drug and could damage eye
U.S. Marshals have seized 12,682 applicator tubes of Age Intervention Eyelash, a product the FDA claims could cause vision problems. Authorities estimated the seized tubes to be worth about $2 million. Jan Marini Skin Research Inc., the San Jose, Calif.-based seller and distributor of the product, has touted Age Intervention Eyelash as a way to grow longer lashes. But the FDA considers the product to be an unapproved and misbranded drug. The agency claims the product contains bimatoprost (Lumigan, Allergan), a drug used to treat elevated eye pressure. Bimatoprost patients who use Age Intervention Eyelash can damage their optic nerves, which can lead to poor vision and possibly blindness. Consumers, dermatologists, and others who have Age Intervention Eyelash should immediately discontinue using the product and discard it.
Click here to see more articles from Drug Topics Daily News.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
